Skip to main content
. 2015 Apr 23;10:3131–3146. doi: 10.2147/IJN.S80150

Figure 12.

Figure 12

Schematic diagram of binding position between the ligand and its corresponding BRAF(V600E) protein. (A) Aknadicine, (B) 16beta-hydroxy-19s-vindolinine N-oxide, and (C) the control.

Note: The two candidates are relatively stable than the control.